SG Americas Securities’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,761
Closed -$287K 3338
2023
Q3
$287K Buy
+1,761
New +$416K ﹤0.01% 2102
2023
Q2
Sell
-1,342
Closed -$370K 2924
2023
Q1
$370K Buy
+1,342
New +$493K ﹤0.01% 1946
2022
Q4
Sell
-536
Closed -$128K 3289
2022
Q3
$128K Sell
536
-653
-55% -$175K ﹤0.01% 2664
2022
Q2
$265K Buy
+1,189
New +$512K ﹤0.01% 2468
2022
Q1
Sell
-1,806
Closed -$1.25M 3307
2021
Q4
$1.25M Buy
1,806
+687
+61% +$508K 0.01% 1476
2021
Q3
$830K Buy
+1,119
New +$763K ﹤0.01% 2064

Other funds holding OM

SG Americas Securities's OM Position: Q4 2023 in Review

SG Americas Securities sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1,761 shares — an estimated $287K sold.

SG Americas Securities first reported a position in OM in Q3 2021 and held it in 6 quarters. The position peaked at $1.25M in Q4 2021. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • SG Americas Securities reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • SG Americas Securities sold 1,761 Outset Medical shares in Q4 2023, an estimated $287K.
  • SG Americas Securities first reported a position in Outset Medical in Q3 2021 and held it in 6 quarters.
  • SG Americas Securities's Outset Medical position peaked at $1.25M in Q4 2021.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on SG Americas Securities's 13F filing for Q4 2023, filed 12 Jan 2024.